−0.0029USD
−495.04 KUSD
2.76 KUSD
58.44 M
About Cell MedX Corp.
Sector
Industry
CEO
David M. Jeffs
Website
Headquarters
West Vancouver
Founded
2010
FIGI
BBG00475SGM2
Cell MedX Corp. is a biotech company, which engages in the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include Microcurrent Therapy and eBalance Systems. The company was founded on March 19, 2010, and is headquartered in Carson City, NV.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CMXC is 0.0220 USD — it has decreased by 31.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cell MedX Corp. stocks are traded under the ticker CMXC.
CMXC stock is 45.45% volatile and has beta coefficient of 15.45 K. Check out the list of the most volatile stocks — is Cell MedX Corp. there?
Yes, you can track Cell MedX Corp. financials in yearly and quarterly reports right on TradingView.
CMXC stock has fallen by 37.14% compared to the previous week, the month change is a 26.17% fall, over the last year Cell MedX Corp. has showed a 2.20 M% increase.
CMXC net income for the last quarter is 119.97 K USD, while the quarter before that showed −60.55 K USD of net income which accounts for 298.15% change. Track more Cell MedX Corp. financial stats to get the full picture.
Today Cell MedX Corp. has the market capitalization of 11.59 M, it has decreased by 22.92% over the last week.
No, CMXC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cell MedX Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cell MedX Corp. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cell MedX Corp. stock shows the strong sell signal. See more of Cell MedX Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cell MedX Corp. EBITDA is −216.16 K USD, and current EBITDA margin is −16.21 K%. See more stats in Cell MedX Corp. financial statements.